Physician profile
Eav K Lim
NPI 1952694747
$4,303.29
in general payments reported to CMS, 2019-2025
16 companies · $1,689 in 2025
The $1,689 reported for 2025 was more than what 76% of Gynecologic Oncology providers received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,551 · 2020: $65.32 · 2021: $407 · 2022: $71.02 · 2023: $217 · 2024: $302 · 2025: $1,689.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,153 · Travel and Lodging: $56.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,153.03 |
| Travel and Lodging | $56.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,601.12 | 2019-2025 | |
| Eisai INC. | $336.74 | 2022-2025 | |
| Glaxosmithkline, LLC. | $266.52 | 2020-2023 | Jemperli |
| Merck Sharp & Dohme LLC | $246.50 | 2019-2025 | Lynparza, Keytruda |
| Baxter Healthcare | $113.02 | 2025 | Tisseel |
| Astellas Pharma US INC | $103.47 | 2024 | Veozah |
| Genmab U.S., INC. | $101.22 | 2024 | Tivdak |
| Astrazeneca Pharmaceuticals LP | $98.28 | 2020-2022 | |
| Ethicon US, LLC | $91.37 | 2019 | |
| Caris Mpi, INC. | $89.54 | 2025 | Mi Cancer Seek |
| Urocure LLC | $89.01 | 2021 | |
| Sanara Medtech INC. | $80.56 | 2021 | |
| Clovis Oncology, INC. | $56.06 | 2019 | |
| Smith+Nephew, INC. | $17.47 | 2020 | |
| Conmed Corporation | $12.41 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eav Lim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.